Top Markets
Coin of the day
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
株式のランク #32097
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
株価
$0.21483059
最終同期: 2024-05-07
時価総額
$11.13M
変化(1日)
0.34%
変化(1年)
0.00%
CA
取引 Antibe Therapeutics Inc. (ATE)

カテゴリー

Antibe Therapeutics Inc.(ATE)の株価履歴
終値の最高値: $0.21 (2024-05-01)

終値の最安値: $5.29 (2013-06-01)
Antibe Therapeutics Inc. の株価履歴(2013 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2024 -64.54%
2023 70.18%
2022 -33.02%
2021 -82.13%
2020 -5.82%
2019 63.59%
2018 69.29%
2017 -9.13%
2016 -2.14%
2015 -69.92%
2014 -18.37%
2013 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$110.69 -15.03%
US
$331.82 -13.05%
US
$90.44 -2.55%
IE
$51.45 -50.08%
US
$90.82 15.99%
US